Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
SCYL3	57147	broad.mit.edu	37	1	169858003	169858003	+	5'UTR	SNP	C	C	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr1:169858003C>T	ENST00000367772.4	-	0	176				SCYL3_ENST00000470238.1_5'UTR|SCYL3_ENST00000367770.1_5'UTR|SCYL3_ENST00000367771.5_5'UTR	NM_181093.3	NP_851607.2	Q8IZE3	PACE1_HUMAN	SCY1-like 3 (S. cerevisiae)	NA		NA		NA	cell migration	Golgi apparatus|lamellipodium	ATP binding|protein binding|protein kinase activity		NA	breast(2)|central_nervous_system(1)|endometrium(3)|kidney(3)|large_intestine(7)|lung(5)|ovary(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	27	all_hematologic(923;0.0922)|Acute lymphoblastic leukemia(37;0.181)					TGAGGCAGTACTGCCACTCTT	0.408	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						109	100	103	NA	NA	NA	NA	1		NA								NA			NA				169858003		2203	4300	6503	SO:0001623	5_prime_UTR_variant			ENSG00000000457	HGNC:19285	NM_181093	Approved	uc001ggs.3	NA	A8K8Z2|Q5THA6|Q5THA8|Q8IZN9|Q96C56|Q9UBK6	ENST00000367772.4	37	CCDS1287.1																																																																																			SCYL3-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		38.591068	KEEP		-	39.130997	0.363636	12	21	---	---	---	---	1	0.9996868	15	15	0	56	15	25	0	56	2	0	0	0	0	0	0	15	25	0	56	2	TP
SLC5A7	60482	broad.mit.edu	37	2	108627021	108627021	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr2:108627021G>T	ENST00000264047.2	+	9	1723	c.1447G>T	c.(1447-1449)Gcc>Tcc	p.A483S	SLC5A7_ENST00000540517.1_Missense_Mutation_p.A378S|SLC5A7_ENST00000409059.1_Missense_Mutation_p.A483S	NM_021815.2	NP_068587.1	Q9GZV3	SC5A7_HUMAN	solute carrier family 5 (sodium/choline cotransporter), member 7	483		NA		NA	acetylcholine biosynthetic process|neurotransmitter secretion	integral to membrane|plasma membrane	choline:sodium symporter activity		NA	NS(1)|breast(1)|central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(5)|lung(23)|ovary(2)|pancreas(1)|prostate(1)|skin(7)|upper_aerodigestive_tract(2)|urinary_tract(2)	49					Choline(DB00122)	TAAAACACTTGCCATGGTTAC	0.373	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						99	98	98	NA	NA	NA	NA	2		NA								NA			NA				108627021		2203	4300	6503	SO:0001583	missense			ENSG00000115665	HGNC:14025		Approved	uc002tdv.3	NA	Q53TF2	ENST00000264047.2	37	CCDS2074.1	.	.	.	.	.	.	.	.	.	.	G	3.722	-0.057251	0.07317	.	.	ENSG00000115665	ENST00000409059;ENST00000540517;ENST00000264047	D;D;D	0.92446	-2.81;-3.04;-2.81	5.95	3.11	0.35812	.	0.147724	0.64402	N	0.000008	D	0.86682	0.5991	L	0.38649	1.16	0.43564	D	0.995889	B	0.02656	0.0	B	0.09377	0.004	T	0.77661	-0.2504	10	0.15499	T	0.54	-12.1308	14.8354	0.70180	0.0:0.0:0.4871:0.5129	.	483	Q9GZV3	SC5A7_HUMAN	S	483;378;483	ENSP00000387346:A483S;ENSP00000445351:A378S;ENSP00000264047:A483S	ENSP00000264047:A483S	A	+	1	0	SLC5A7	107993453	0.999000	0.42202	0.388000	0.26195	0.248000	0.25809	2.896000	0.48656	0.370000	0.24538	-0.158000	0.13435	GCC	SLC5A7-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253562.1	9.783155	KEEP		+	19.039933	0.121212	8	58	---	---	---	---	0	0	0	0	0	84	10	71	0	84	2	1	1	106	772	1	862	10	71	0	84	8	TP
COL3A1	1281	broad.mit.edu	37	2	189873778	189873778	+	Silent	SNP	G	G	A	rs35759441	byFrequency|by1000genomes	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr2:189873778G>A	ENST00000304636.3	+	48	3824	c.3654G>A	c.(3652-3654)ccG>ccA	p.P1218P	COL3A1_ENST00000317840.5_Silent_p.P915P	NM_000090.3	NP_000081.1	P02461	CO3A1_HUMAN	collagen, type III, alpha 1	1218		NA		NA	axon guidance|cell-matrix adhesion|collagen biosynthetic process|collagen fibril organization|fibril organization|heart development|integrin-mediated signaling pathway|negative regulation of immune response|peptide cross-linking|platelet activation|response to cytokine stimulus|response to radiation|skin development|transforming growth factor beta receptor signaling pathway	collagen type III|extracellular space	extracellular matrix structural constituent|integrin binding|platelet-derived growth factor binding		NA	NS(2)|breast(1)|central_nervous_system(7)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(17)|lung(60)|ovary(4)|pancreas(1)|prostate(5)|skin(10)|upper_aerodigestive_tract(3)|urinary_tract(3)	126			OV - Ovarian serous cystadenocarcinoma(117;0.0106)|Epithelial(96;0.141)		Collagenase(DB00048)|Palifermin(DB00039)	GTTTTGCCCCGTATTATGGAG	0.498	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						109	115	113	NA	NA	NA	NA	2		NA								NA			NA				189873778		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000168542	HGNC:2201	NM_000090	Approved	uc002uqj.1	NA	D3DPH4|P78429|Q15112|Q16403|Q53S91|Q541P8|Q6LDB3|Q6LDJ2|Q6LDJ3|Q7KZ56|Q8N6U4|Q9UC88|Q9UC89|Q9UC90|Q9UC91	ENST00000304636.3	37	CCDS2297.1																																																																																			COL3A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255899.3	32.701674	KEEP		+	51.321845	0.136986	20	126	---	---	---	---	1	1	4	1203	0	169	23	158	0	169	2	0	0	0	0	0	0	23	158	0	169	2	TP
MINA	84864	broad.mit.edu	37	3	97677910	97677910	+	Silent	SNP	A	A	G			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr3:97677910A>G	ENST00000333396.6	-	4	1248	c.666T>C	c.(664-666)caT>caC	p.H222H	MINA_ENST00000360258.4_Silent_p.H222H|MINA_ENST00000330299.2_Silent_p.H222H|MINA_ENST00000394198.2_Silent_p.H222H	NM_001042533.2|NM_032778.5	NP_001035998.1|NP_116167.3	Q8IUF8	MINA_HUMAN	MYC induced nuclear antigen	222	JmjC.	NA		NA	ribosome biogenesis	cytoplasm|nucleolus			NA	breast(2)|endometrium(1)|large_intestine(1)|lung(8)|ovary(1)	13						GCATAAACTCATGCACCGGCC	0.542	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						104	79	88	NA	NA	NA	NA	3		NA								NA			NA				97677910		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000170854	HGNC:19441	NM_032778	Approved	uc003dsb.1	NA	D3DN35|Q6AHW4|Q6SKS0|Q8IU69|Q8IUF6|Q8IUF7|Q96C17|Q96KB0	ENST00000333396.6	37	CCDS43114.1																																																																																			MINA-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000359244.1	87.12755	KEEP		-	89.721595	0.322581	30	63	---	---	---	---	1	1	32	63	0	98	39	86	0	98	2	0	0	0	0	0	0	39	86	0	98	2	TP
ST3GAL6	10402	broad.mit.edu	37	3	98491723	98491723	+	Silent	SNP	C	C	T	rs143638537		GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr3:98491723C>T	ENST00000394162.1	+	5	701	c.234C>T	c.(232-234)agC>agT	p.S78S	ST3GAL6_ENST00000462152.1_3'UTR|ST3GAL6_ENST00000265261.6_5'UTR|ST3GAL6_ENST00000483910.1_Silent_p.S78S|ST3GAL6_ENST00000468553.1_Silent_p.S78S	NM_006100.2	NP_006091.1	Q9Y274	SIA10_HUMAN	ST3 beta-galactoside alpha-2,3-sialyltransferase 6	78		NA		NA	amino sugar metabolic process|glycolipid metabolic process|protein glycosylation|protein lipoylation	integral to Golgi membrane	sialyltransferase activity		NA	breast(2)|central_nervous_system(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(7)|lung(7)|ovary(1)	19						TGTATGGTAGCGATAAGTTTG	0.393	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	C		2,4404	4.2+/-10.8	0,2,2201	219	199	206	NA	234	0.4	1	3	dbSNP_134	206	0,8600		0,0,4300	no	coding-synonymous	ST3GAL6	NM_006100.2	NA	0,2,6501	TT,TC,CC	NA	0.0,0.0454,0.0154		78/332	98491723	2,13004	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000064225	HGNC:18080	NM_006100	Approved	uc010hpd.4	NA	B2RCH2|D3DN39	ENST00000394162.1	37	CCDS2933.1																																																																																			ST3GAL6-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		61.191305	KEEP		+	63.930372	0.297297	22	52	---	---	---	---	1	1	31	96	0	194	31	71	0	194	2	0	0	0	0	0	0	31	71	0	194	2	TP
DCHS2	54798	broad.mit.edu	37	4	155219544	155219544	+	Silent	SNP	A	A	G			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr4:155219544A>G	ENST00000357232.3	-	18	4556	c.4557T>C	c.(4555-4557)gaT>gaC	p.D1519D		NM_017639.3	NP_060109.2	Q6V1P9	PCD23_HUMAN	dachsous cadherin-related 2	1519	Cadherin 13.	NA		NA	homophilic cell adhesion	integral to membrane|plasma membrane	calcium ion binding		NA	NS(1)|breast(2)|central_nervous_system(1)|cervix(3)|endometrium(8)|kidney(5)|large_intestine(54)|lung(63)|ovary(4)|pancreas(1)|prostate(14)|skin(12)|stomach(4)|upper_aerodigestive_tract(2)|urinary_tract(2)	176	all_hematologic(180;0.208)	Renal(120;0.0854)		LUSC - Lung squamous cell carcinoma(193;0.107)		CAGAAGCCTCATCAGTCAGAA	0.478	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						132	126	128	NA	NA	NA	NA	4		NA								NA			NA				155219544		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:23111	NM_017639	Approved	uc003inw.2	NA	Q4W5P9|Q6ZS61|Q9NXU8	ENST00000357232.3	37	CCDS3785.1																																																																																			DCHS2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000365281.1	11.209879	KEEP		-	29.883108	0.101695	12	106	---	---	---	---	0	0	0	0	0	120	15	130	0	120	2	1	1	124	1084	3	1289	15	130	0	120	9	TP
RXFP1	59350	broad.mit.edu	37	4	159573137	159573137	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr4:159573137C>T	ENST00000307765.5	+	18	2455	c.2204C>T	c.(2203-2205)cCg>cTg	p.P735L	RXFP1_ENST00000448688.2_Missense_Mutation_p.P630L|RXFP1_ENST00000343542.5_Missense_Mutation_p.P687L|RXFP1_ENST00000460056.2_Missense_Mutation_p.P654L|RXFP1_ENST00000470033.1_Missense_Mutation_p.P702L	NM_001253727.1|NM_001253728.1|NM_001253730.1|NM_001253732.1|NM_001253733.1|NM_021634.3	NP_001240656.1|NP_001240657.1|NP_001240659.1|NP_001240661.1|NP_001240662.1|NP_067647.2	Q9HBX9	RXFP1_HUMAN	relaxin/insulin-like family peptide receptor 1	735		NA		NA		integral to membrane|plasma membrane	G-protein coupled receptor activity|metal ion binding		NA	breast(2)|endometrium(3)|haematopoietic_and_lymphoid_tissue(3)|kidney(1)|large_intestine(5)|liver(2)|lung(22)|prostate(1)|skin(10)	49	all_hematologic(180;0.24)	Renal(120;0.0854)		COAD - Colon adenocarcinoma(41;0.0219)		TTAATGAAGCCGGACCTTTTC	0.428	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						118	111	113	NA	NA	NA	NA	4		NA								NA			NA				159573137		1881	4122	6003	SO:0001583	missense			ENSG00000171509	HGNC:19718	NM_021634	Approved	uc003ipz.3	NA	B4DTV2|Q2M215|Q3KU24|Q3KU25|Q3KU26	ENST00000307765.5	37	CCDS43276.1	.	.	.	.	.	.	.	.	.	.	C	14.73	2.623035	0.46840	.	.	ENSG00000171509	ENST00000460056;ENST00000307765;ENST00000448688;ENST00000343542;ENST00000470033;ENST00000440678	T;T;T;T;T	0.71103	-0.36;-0.49;-0.34;-0.54;-0.46	5.75	5.75	0.90469	.	0.197519	0.45361	D	0.000367	T	0.70219	0.3199	L	0.57536	1.79	0.58432	D	0.999999	P;P;P;D;P;B;P;P	0.55605	0.901;0.952;0.681;0.972;0.786;0.346;0.952;0.952	B;B;B;B;B;B;B;B	0.41174	0.142;0.189;0.142;0.349;0.275;0.034;0.189;0.189	T	0.74788	-0.3546	10	0.59425	D	0.04	.	19.9449	0.97179	0.0:1.0:0.0:0.0	.	746;762;630;687;702;654;605;735	B3KV27;B4DGP2;B4DHD1;Q9HBX9-4;Q9HBX9-2;E9PCA3;Q59H16;Q9HBX9	.;.;.;.;.;.;.;RXFP1_HUMAN	L	654;735;630;687;702;605	ENSP00000423306:P654L;ENSP00000303248:P735L;ENSP00000414885:P630L;ENSP00000345889:P687L;ENSP00000420712:P702L	ENSP00000303248:P735L	P	+	2	0	RXFP1	159792587	1.000000	0.71417	0.803000	0.32268	0.092000	0.18411	6.122000	0.71608	2.696000	0.92011	0.655000	0.94253	CCG	RXFP1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000314865.1	28.543411	KEEP		+	37.1897	0.1625	13	67	---	---	---	---	0	0.1992395	0	5	0	153	16	84	0	153	2	1	1	138	886	0	1158	16	84	0	153	2	TP
CSNK1G3	1456	broad.mit.edu	37	5	122893207	122893207	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr5:122893207G>A	ENST00000395412.1	+	4	957	c.238G>A	c.(238-240)Gca>Aca	p.A80T	CSNK1G3_ENST00000395411.1_Missense_Mutation_p.A80T|CSNK1G3_ENST00000512718.3_Missense_Mutation_p.A5T|CSNK1G3_ENST00000345990.4_Missense_Mutation_p.A80T|CSNK1G3_ENST00000511130.2_Intron|CSNK1G3_ENST00000521364.1_Missense_Mutation_p.A80T|CSNK1G3_ENST00000361991.2_Missense_Mutation_p.A80T|CSNK1G3_ENST00000360683.2_Missense_Mutation_p.A80T|CSNK1G3_ENST00000510842.2_Missense_Mutation_p.A80T	NM_001044723.1	NP_001038188.1	Q9Y6M4	KC1G3_HUMAN	casein kinase 1, gamma 3	80	Protein kinase.	NA		NA	Wnt receptor signaling pathway	cytoplasm	ATP binding|protein serine/threonine kinase activity		NA	autonomic_ganglia(1)|breast(1)|endometrium(2)|kidney(2)|large_intestine(3)|liver(1)|lung(3)|prostate(1)|skin(1)	15		all_cancers(142;0.0156)|Prostate(80;0.0322)|Lung NSC(810;0.245)	KIRC - Kidney renal clear cell carcinoma(527;0.165)|Kidney(363;0.229)	OV - Ovarian serous cystadenocarcinoma(64;0.000121)|Epithelial(69;0.000227)|all cancers(49;0.00176)		GAAATCAAGAGCACCACAGCT	0.308	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(187;2868 2964 4353 6297)					NA		NA		NA		0							NA						59	64	62	NA	NA	NA	NA	5		NA								NA			NA				122893207		2203	4296	6499	SO:0001583	missense			ENSG00000151292	HGNC:2456	NM_004384	Approved	uc031skv.1	NA	Q86WZ7|Q9Y6M3	ENST00000395412.1	37	CCDS43355.1	.	.	.	.	.	.	.	.	.	.	G	19.68	3.873695	0.72180	.	.	ENSG00000151292	ENST00000395412;ENST00000395411;ENST00000345990;ENST00000512718;ENST00000521364;ENST00000510842;ENST00000361991;ENST00000360683	T;T;T;T;T;T;T;T	0.65178	-0.14;-0.14;-0.14;0.98;-0.14;-0.14;-0.14;-0.14	5.29	5.29	0.74685	Serine/threonine-protein kinase-like domain (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);	0.000000	0.64402	D	0.000001	T	0.78323	0.4265	M	0.69358	2.11	0.80722	D	1	D;B;B;B;B	0.76494	0.999;0.035;0.079;0.035;0.205	D;B;B;B;B	0.77004	0.989;0.098;0.147;0.098;0.299	T	0.78548	-0.2162	10	0.59425	D	0.04	.	18.5899	0.91206	0.0:0.0:1.0:0.0	.	5;80;80;80;80	B4DSH2;A8K040;Q9Y6M4-3;Q9Y6M4;Q9Y6M4-2	.;.;.;KC1G3_HUMAN;.	T	80;80;80;5;80;80;80;80	ENSP00000378807:A80T;ENSP00000378806:A80T;ENSP00000334735:A80T;ENSP00000421998:A5T;ENSP00000429412:A80T;ENSP00000423838:A80T;ENSP00000354942:A80T;ENSP00000353904:A80T	ENSP00000334735:A80T	A	+	1	0	CSNK1G3	122921106	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	8.182000	0.89698	2.865000	0.98341	0.655000	0.94253	GCA	CSNK1G3-203	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		13.399946	KEEP		+	13.399946	0.5	4	4	---	---	---	---	1	0.999842	8	21	0	48	7	6	0	48	2	0	0	0	0	0	0	7	6	0	48	2	TP
FLT4	2324	broad.mit.edu	37	5	180048765	180048765	+	Silent	SNP	G	G	A			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr5:180048765G>A	ENST00000261937.6	-	13	1875	c.1797C>T	c.(1795-1797)caC>caT	p.H599H	FLT4_ENST00000424276.2_5'UTR|FLT4_ENST00000502649.1_Silent_p.H599H|FLT4_ENST00000393347.3_Silent_p.H599H	NM_182925.4	NP_891555.2	P35916	VGFR3_HUMAN	fms-related tyrosine kinase 4	599	Ig-like C2-type 6.	NA		NA	positive regulation of cell proliferation	integral to plasma membrane	ATP binding|protein phosphatase binding|vascular endothelial growth factor receptor activity	p.H599H(2)|p.H409H(1)	NA	NS(1)|breast(3)|central_nervous_system(2)|endometrium(1)|kidney(6)|large_intestine(5)|liver(2)|lung(37)|ovary(6)|prostate(1)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	71	all_cancers(89;2.21e-05)|all_epithelial(37;5.29e-06)|Renal(175;0.000159)|Lung NSC(126;0.00199)|all_lung(126;0.00351)|Breast(19;0.114)	all_cancers(40;0.00245)|Medulloblastoma(196;0.0133)|all_neural(177;0.0199)|all_hematologic(541;0.163)|Ovarian(839;0.238)	Kidney(164;2.23e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178)	all cancers(165;0.134)	Sorafenib(DB00398)|Sunitinib(DB01268)	CGTGCGCATCGTGCAGCGTGG	0.657	NA	NA		NA			NA				NA	NA	G	1	5e-04	0.002	NA	2184	NA	1	,	,	NA	3e-04	NA	NA	NA	4e-04	0.95	EXOME	NA	NA	6e-04	SNP	Colon(97;1075 1466 27033 27547 35871)					NA		NA		NA		3	Substitution - coding silent(3)	breast(3)					NA						87	78	81	NA	NA	NA	NA	5		NA								NA			NA				180048765		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000037280	HGNC:3767		Approved	uc003mlz.4	NA	Q16067|Q86W07	ENST00000261937.6	37	CCDS4457.1																																																																																			FLT4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253527.4	36.66009	KEEP		-	42.748623	0.207792	16	61	---	---	---	---	0	0.1631815	0	4	0	127	18	82	0	127	2	1	1	342	1192	3	1575	18	82	0	127	9	TP
HIST1H2BK	85236	broad.mit.edu	37	6	27114602	27114602	+	5'UTR	SNP	G	G	A			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr6:27114602G>A	ENST00000396891.4	-	0	17				HIST1H2AH_ENST00000377459.1_5'Flank|MIR3143_ENST00000584253.1_RNA|HIST1H2BK_ENST00000356950.1_5'Flank	NM_080593.2	NP_542160.1	O60814	H2B1K_HUMAN	histone cluster 1, H2bk	NA		NA		NA	defense response to bacterium|nucleosome assembly	nucleosome|nucleus	DNA binding		NA	breast(1)|kidney(1)|large_intestine(3)|lung(5)|ovary(1)|prostate(1)|skin(1)	13						ACGAGCCTGAGACGAGCAGCA	0.527	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	G		12,4394	19.1+/-41.9	0,12,2191	34	35	35	NA	NA	-1	0	6		35	0,8600		0,0,4300	no	utr-5	HIST1H2BK	NM_080593.2	NA	0,12,6491	AA,AG,GG	NA	0.0,0.2724,0.0923			27114602	12,12994	2203	4300	6503	SO:0001623	5_prime_UTR_variant			ENSG00000197903	HGNC:13954	NM_080593	Approved	uc003nix.2	NA	A8K7P7|Q2VPI7	ENST00000396891.4	37	CCDS4621.1																																																																																			HIST1H2BK-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		42.808757	KEEP		-	44.043251	0.326087	15	31	---	---	---	---	1	1	49	67	0	46	17	36	0	46	2	0	0	0	0	0	0	17	36	0	46	2	TP
PEG10	23089	broad.mit.edu	37	7	94293026	94293026	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr7:94293026A>G	ENST00000482108.1	+	2	637	c.158A>G	c.(157-159)gAg>gGg	p.E53G	PEG10_ENST00000488574.1_Missense_Mutation_p.E53G	NM_001040152.1|NM_001172438.1|NM_001184962.1	NP_001035242.1|NP_001165909.1|NP_001171891.1	Q86TG7	PEG10_HUMAN	paternally expressed 10	53		NA		NA	apoptosis|cell differentiation|negative regulation of transforming growth factor beta receptor signaling pathway	cytoplasm|nucleus	DNA binding|protein binding|zinc ion binding		NA	NS(1)|central_nervous_system(1)|endometrium(3)|large_intestine(3)|lung(9)|prostate(3)|skin(1)	21	all_cancers(62;8.26e-10)|all_epithelial(64;5.59e-09)|Lung NSC(181;0.188)|all_lung(186;0.215)		STAD - Stomach adenocarcinoma(171;0.0031)			CCCACCCCTGAGGATGAGGAT	0.582	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						52	62	59	NA	NA	NA	NA	7		NA								NA			NA				94293026		2091	4224	6315	SO:0001583	missense			ENSG00000242265	HGNC:14005	NM_015068	Approved	uc011kie.2	NA	Q96A68|Q9UPV1	ENST00000482108.1	37	CCDS55126.1	.	.	.	.	.	.	.	.	.	.	A	6.141	0.394250	0.11638	.	.	ENSG00000242265	ENST00000482108;ENST00000488574	T;T	0.12465	2.68;2.68	4.35	3.1	0.35709	.	.	.	.	.	T	0.06690	0.0171	N	0.08118	0	0.18873	N	0.999983	B;B	0.23058	0.079;0.01	B;B	0.21546	0.035;0.009	T	0.29274	-1.0017	9	0.30078	T	0.28	.	6.6966	0.23203	0.7895:0.0:0.0:0.2105	.	129;53	B4DSP0;Q86TG7	.;PEG10_HUMAN	G	53	ENSP00000417587:E53G;ENSP00000418944:E53G	ENSP00000417587:E53G	E	+	2	0	PEG10	94130962	0.942000	0.31987	0.836000	0.33094	0.456000	0.32438	2.426000	0.44731	1.973000	0.57446	0.454000	0.30748	GAG	PEG10-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000340751.1	15.93357	KEEP		+	18.242294	0.206897	6	23	---	---	---	---	1	0.9954585	23	37	0	32	6	30	0	32	2	0	0	0	0	0	0	6	30	0	32	2	TP
FAM91A1	157769	broad.mit.edu	37	8	124801932	124801932	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr8:124801932G>A	ENST00000334705.7	+	15	1604	c.1358G>A	c.(1357-1359)cGt>cAt	p.R453H	FAM91A1_ENST00000521166.1_Missense_Mutation_p.R453H	NM_144963.2	NP_659400.2	Q658Y4	F91A1_HUMAN	family with sequence similarity 91, member A1	453		NA		NA				p.R453H(1)	NA	breast(4)|central_nervous_system(3)|endometrium(6)|kidney(2)|large_intestine(3)|lung(6)|ovary(1)|pancreas(1)|prostate(1)|skin(1)	28	Lung NSC(37;8.76e-13)|Ovarian(258;0.00744)|all_neural(195;0.0741)		STAD - Stomach adenocarcinoma(47;0.00192)			CTGTTTCTGCGTCATAACAAA	0.358	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	breast(1)					NA						100	89	92	NA	NA	NA	NA	8		NA								NA			NA				124801932		1889	4110	5999	SO:0001583	missense			ENSG00000176853	HGNC:26306	NM_144963	Approved	uc003yqv.3	NA	Q658T5|Q8TE89	ENST00000334705.7	37	CCDS6346.2	.	.	.	.	.	.	.	.	.	.	G	34	5.377761	0.95945	.	.	ENSG00000176853	ENST00000521166;ENST00000334705	T;T	0.60040	0.22;0.22	5.17	5.17	0.71159	.	0.000000	0.85682	D	0.000000	T	0.69575	0.3126	M	0.79258	2.445	0.80722	D	1	D;D	0.67145	0.989;0.996	P;P	0.50537	0.549;0.643	T	0.75271	-0.3376	10	0.66056	D	0.02	.	19.0348	0.92972	0.0:0.0:1.0:0.0	.	453;453	E7ER68;Q658Y4	.;F91A1_HUMAN	H	453	ENSP00000429491:R453H;ENSP00000335082:R453H	ENSP00000335082:R453H	R	+	2	0	FAM91A1	124871113	1.000000	0.71417	1.000000	0.80357	0.984000	0.73092	7.433000	0.80362	2.577000	0.86979	0.557000	0.71058	CGT	FAM91A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256607.1	47.120338	KEEP		+	47.222833	0.441176	15	19	---	---	---	---	1	0.999988	13	25	0	74	17	24	0	74	2	0	0	0	0	0	0	17	24	0	74	2	TP
IFNE	338376	broad.mit.edu	37	9	21481720	21481720	+	5'UTR	SNP	C	C	G			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr9:21481720C>G	ENST00000448696.3	-	0	592				MIR31HG_ENST00000304425.3_RNA	NM_176891.4	NP_795372.1	Q86WN2	IFNE_HUMAN	interferon, epsilon	NA		NA		NA	defense response|response to virus	extracellular space	cytokine activity|cytokine receptor binding		NA	large_intestine(2)|lung(1)|skin(1)	4						GCTACTTATCCCTGCATAGAC	0.398	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						36	36	36	NA	NA	NA	NA	9		NA								NA			NA				21481720		2187	4243	6430	SO:0001623	5_prime_UTR_variant			ENSG00000184995	HGNC:18163	NM_176891	Approved	uc003zpg.3	NA		ENST00000448696.3	37	CCDS34997.1																																																																																			IFNE-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000051901.2	27.859834	KEEP		-	29.237008	0.28125	9	23	---	---	---	---	1	0.1052632	2	0	2	68	11	25	2	68	2	0	0	0	0	0	0	11	25	2	68	2	TP
ZNF462	58499	broad.mit.edu	37	9	109690780	109690780	+	Silent	SNP	C	C	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr9:109690780C>T	ENST00000277225.5	+	3	4876	c.4587C>T	c.(4585-4587)ggC>ggT	p.G1529G	ZNF462_ENST00000457913.1_Silent_p.G1529G|ZNF462_ENST00000441147.2_Silent_p.G374G			Q96JM2	ZN462_HUMAN	zinc finger protein 462	1529		NA		NA	transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding		NA	NS(2)|autonomic_ganglia(2)|breast(5)|central_nervous_system(4)|cervix(1)|endometrium(16)|haematopoietic_and_lymphoid_tissue(1)|kidney(17)|large_intestine(20)|lung(32)|ovary(5)|prostate(6)|skin(2)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(1)	119						GCATCCACGGCGTACTGACCC	0.542	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	C		0,4406		0,0,2203	99	74	83	NA	4587	-1.8	1	9		83	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous	ZNF462	NM_021224.4	NA	0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077		1529/2507	109690780	1,13005	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000148143	HGNC:21684	NM_021224	Approved	uc004bcz.3	NA	Q5T0T4|Q8N408	ENST00000277225.5	37	CCDS35096.1																																																																																			ZNF462-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000053532.2	38.517172	KEEP		+	41.068768	0.272727	15	40	---	---	---	---	1	0.9717475	12	7	0	45	18	48	0	45	2	0	0	0	0	0	0	18	48	0	45	2	TP
PALM2	114299	broad.mit.edu	37	9	112642886	112642886	+	Missense_Mutation	SNP	A	A	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr9:112642886A>T	ENST00000448454.2	+	4	188	c.188A>T	c.(187-189)gAa>gTa	p.E63V	AKAP2_ENST00000555236.1_Missense_Mutation_p.E61V|AKAP2_ENST00000510514.5_Missense_Mutation_p.E61V|PALM2_ENST00000314527.4_Missense_Mutation_p.E61V|PALM2_ENST00000483909.1_Missense_Mutation_p.E61V|PALM2-AKAP2_ENST00000374530.3_Missense_Mutation_p.E61V|PALM2-AKAP2_ENST00000302798.7_Missense_Mutation_p.E61V|PALM2_ENST00000374531.2_Missense_Mutation_p.E63V					paralemmin 2	NA		NA		NA					NA	breast(1)|endometrium(1)|large_intestine(3)|lung(5)|ovary(2)|pancreas(2)|skin(3)|upper_aerodigestive_tract(1)	18						GGAACTGCCGAAGAGGAGGAA	0.522	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						89	84	86	NA	NA	NA	NA	9		NA								NA			NA				112642886		2203	4300	6503	SO:0001583	missense			ENSG00000243444	HGNC:15845	NM_001037293	Approved		NA		ENST00000448454.2	37		.	.	.	.	.	.	.	.	.	.	A	23.1	4.373886	0.82573	.	.	ENSG00000243444;ENSG00000243444;ENSG00000243444;ENSG00000243444;ENSG00000243444;ENSG00000157654;ENSG00000157654;ENSG00000157654;ENSG00000241978;ENSG00000241978	ENST00000374531;ENST00000448454;ENST00000483909;ENST00000314527;ENST00000497711;ENST00000374530;ENST00000413420;ENST00000302798;ENST00000555236;ENST00000510514	T;T;T;T;T;T;T;T;T;T	0.35605	1.68;1.68;1.7;1.69;1.3;1.99;1.66;2.0;1.99;2.0	5.36	5.36	0.76844	.	0.795057	0.11203	N	0.588579	T	0.58192	0.2105	L	0.57536	1.79	0.35749	D	0.819265	P;P;D;D	0.89917	0.933;0.933;0.998;1.0	P;P;D;D	0.85130	0.624;0.624;0.994;0.997	T	0.62863	-0.6764	10	0.87932	D	0	-19.1311	13.5996	0.62011	1.0:0.0:0.0:0.0	.	61;61;63;63	Q9Y2D5-6;Q9Y2D5-4;Q8IXS6;D3YTA4	.;.;PALM2_HUMAN;.	V	63;63;61;61;47;61;61;61;61;61	ENSP00000363656:E63V;ENSP00000400206:E63V;ENSP00000417525:E61V;ENSP00000323805:E61V;ENSP00000419747:E47V;ENSP00000363654:E61V;ENSP00000397839:E61V;ENSP00000305861:E61V;ENSP00000451476:E61V;ENSP00000421522:E61V	ENSP00000305861:E61V	E	+	2	0	PALM2-AKAP2;PALM2;AKAP2	111682707	1.000000	0.71417	0.918000	0.36340	0.979000	0.70002	4.764000	0.62264	2.175000	0.68902	0.528000	0.53228	GAA	PALM2-201	KNOWN	basic	protein_coding	NA	protein_coding		95.356752	KEEP		+	97.772133	0.339623	36	70	---	---	---	---	1	0.8863846	5	5	0	80	39	79	0	80	2	0	0	0	0	0	0	39	79	0	80	2	TP
COL5A1	1289	broad.mit.edu	37	9	137686950	137686950	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr9:137686950C>T	ENST00000371817.3	+	33	3137	c.2723C>T	c.(2722-2724)cCg>cTg	p.P908L		NM_000093.3|NM_001278074.1	NP_000084.3|NP_001265003.1	P20908	CO5A1_HUMAN	collagen, type V, alpha 1	908	Triple-helical region.	NA	P -> L (found in a renal cell carcinoma case; somatic mutation).	NA	axon guidance|cell adhesion|collagen biosynthetic process|collagen fibril organization|eye morphogenesis|fibril organization|integrin biosynthetic process|skin development|wound healing, spreading of epidermal cells	collagen type V	heparin binding|integrin binding|platelet-derived growth factor binding|proteoglycan binding	p.P908L(1)	NA	NS(1)|breast(3)|central_nervous_system(1)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(26)|liver(2)|lung(36)|ovary(4)|pancreas(4)|prostate(5)|skin(10)|stomach(2)|upper_aerodigestive_tract(2)|urinary_tract(4)	115		Myeloproliferative disorder(178;0.0341)		all cancers(34;2.28e-08)|OV - Ovarian serous cystadenocarcinoma(145;6.03e-08)|Epithelial(140;6.4e-08)|GBM - Glioblastoma multiforme(294;0.131)		AAGCCAGGACCGCGGGGGCAG	0.622	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	kidney(1)					NA						50	58	55	NA	NA	NA	NA	9		NA								NA			NA				137686950		2203	4300	6503	SO:0001583	missense			ENSG00000130635	HGNC:2209	NM_000093	Approved	uc031tfl.1	NA	Q15094|Q5SUX4	ENST00000371817.3	37	CCDS6982.1	.	.	.	.	.	.	.	.	.	.	C	21.4	4.144370	0.77888	.	.	ENSG00000130635	ENST00000371817	D	0.93133	-3.17	4.43	4.43	0.53597	.	0.000000	0.64402	U	0.000001	D	0.92538	0.7630	N	0.17474	0.49	0.80722	D	1	D	0.89917	1.0	D	0.91635	0.999	D	0.89972	0.4094	10	0.14252	T	0.57	.	16.0323	0.80588	0.0:1.0:0.0:0.0	.	908	P20908	CO5A1_HUMAN	L	908	ENSP00000360882:P908L	ENSP00000360882:P908L	P	+	2	0	COL5A1	136826771	1.000000	0.71417	0.995000	0.50966	0.860000	0.49131	6.866000	0.75506	2.017000	0.59298	0.297000	0.19635	CCG	COL5A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054954.2	72.004628	KEEP		+	73.458311	0.343284	23	44	---	---	---	---	1	0.9999907	13	29	0	66	30	57	0	66	2	0	0	0	0	0	0	30	57	0	66	2	TP
PTEN	5728	broad.mit.edu	37	10	89653783	89653783	+	Splice_Site	SNP	T	T	G			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr10:89653783T>G	ENST00000371953.3	+	2	1438	c.79_splice	c.e2-1	p.Y27_splice		NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	27	Phosphatase tensin-type.	NA	Y -> S (loss of phosphatase activity towards Ins(1,3,4,5)P4).	NA	activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.0?(37)|p.?(8)|p.Y27fs*1(3)|p.Y27fs*16(1)|p.Y27*(1)	NA	NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		AGTACTCAGATATTTATCCAA	0.294	NA	31	"""D, Mis, N, F, S"""	NA	"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""	NA		Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10	10q23.3	5728	phosphatase and tensin homolog gene	NA	"""L, E, M, O"""	50	Whole gene deletion(37)|Unknown(8)|Deletion - Frameshift(4)|Substitution - Nonsense(1)	prostate(14)|central_nervous_system(9)|skin(8)|haematopoietic_and_lymphoid_tissue(4)|lung(4)|ovary(3)|endometrium(2)|breast(2)|soft_tissue(1)|urinary_tract(1)|NS(1)|kidney(1)					NA						98	98	98	NA	NA	NA	NA	10		NA								NA			NA				89653783		2203	4292	6495	SO:0001630	splice_region_variant	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	NA	B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	T	47	13.598563	0.99752	.	.	ENSG00000171862	ENST00000371953	.	.	.	5.19	5.19	0.71726	.	0.071107	0.64402	D	0.000018	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.0135	0.64511	0.0:0.0:0.0:1.0	.	.	.	.	X	27	.	.	Y	+	3	2	PTEN	89643763	1.000000	0.71417	1.000000	0.80357	0.979000	0.70002	5.599000	0.67592	1.959000	0.56917	0.533000	0.62120	TAT	PTEN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049241.1	53.457043	KEEP	Nonsense_Mutation	+	53.817286	0.636364	14	8	---	---	---	---	1	1	49	48	0	81	16	9	0	81	2	0	0	0	0	0	0	16	9	0	81	2	TP
OR52B6	340980	broad.mit.edu	37	11	5602496	5602496	+	Silent	SNP	C	C	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr11:5602496C>T	ENST00000345043.2	+	1	390	c.390C>T	c.(388-390)caC>caT	p.H130H	AC015691.13_ENST00000394793.2_RNA|HBG2_ENST00000380259.2_Intron	NM_001005162.2	NP_001005162.2	Q8NGF0	O52B6_HUMAN	olfactory receptor, family 52, subfamily B, member 6	130		NA		NA	sensory perception of smell	integral to membrane|plasma membrane	olfactory receptor activity		NA	endometrium(1)|kidney(2)|lung(7)|ovary(1)|prostate(1)	12		Medulloblastoma(188;0.00225)|Breast(177;0.0204)|all_neural(188;0.0212)		Epithelial(150;3.56e-09)|BRCA - Breast invasive adenocarcinoma(625;0.135)		TCTTCATTCACTCTGCTGTCC	0.517	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						113	112	112	NA	NA	NA	NA	11		NA								NA			NA				5602496		2201	4297	6498	SO:0001819	synonymous_variant			ENSG00000187747	HGNC:15211	NM_001005162	Approved	uc010qzi.2	NA	Q6IFI7	ENST00000345043.2	37	CCDS41611.1																																																																																			OR52B6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000143397.1	59.180313	KEEP		+	63.718792	0.261364	23	65	---	---	---	---	0	0	0	0	0	103	23	67	0	103	2	1	1	266	714	3	992	23	67	0	103	9	TP
NCKAP1L	3071	broad.mit.edu	37	12	54936426	54936426	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr12:54936426G>A	ENST00000293373.6	+	31	3420	c.3341G>A	c.(3340-3342)cGa>cAa	p.R1114Q	NCKAP1L_ENST00000545638.2_Missense_Mutation_p.R1064Q|RP11-1049A21.2_ENST00000547942.1_RNA	NM_005337.4	NP_005328.2	P55160	NCKPL_HUMAN	NCK-associated protein 1-like	1114		NA		NA	actin polymerization-dependent cell motility|B cell homeostasis|B cell receptor signaling pathway|cortical actin cytoskeleton organization|erythrocyte development|maintenance of cell polarity|myeloid cell homeostasis|negative regulation of apoptosis|negative regulation of interleukin-17 production|negative regulation of interleukin-6 production|negative regulation of myosin-light-chain-phosphatase activity|neutrophil chemotaxis|positive regulation of actin filament polymerization|positive regulation of B cell differentiation|positive regulation of B cell proliferation|positive regulation of CD4-positive, alpha-beta T cell differentiation|positive regulation of CD8-positive, alpha-beta T cell differentiation|positive regulation of cell adhesion mediated by integrin|positive regulation of erythrocyte differentiation|positive regulation of gamma-delta T cell differentiation|positive regulation of neutrophil chemotaxis|positive regulation of phagocytosis, engulfment|positive regulation of T cell proliferation|protein complex assembly|response to drug|T cell homeostasis	cytosol|integral to plasma membrane|membrane fraction|SCAR complex	protein complex binding|protein kinase activator activity|Rac GTPase activator activity	p.R1114Q(1)	NA	NS(3)|breast(2)|central_nervous_system(2)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(12)|lung(37)|ovary(3)|prostate(3)|skin(3)|stomach(2)	80						GTCCTGCTTCGAAATGCCTAT	0.537	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	large_intestine(1)					NA						203	173	183	NA	NA	NA	NA	12		NA								NA			NA				54936426		2203	4300	6503	SO:0001583	missense				HGNC:4862	NM_005337	Approved	uc001sgc.4	NA	Q52LW0	ENST00000293373.6	37	CCDS31813.1	.	.	.	.	.	.	.	.	.	.	G	33	5.249362	0.95305	.	.	ENSG00000123338	ENST00000293373;ENST00000545638	T;T	0.57107	0.42;0.42	5.38	5.38	0.77491	.	0.000000	0.64402	D	0.000001	T	0.69762	0.3147	M	0.62723	1.935	0.58432	D	0.999995	D	0.71674	0.998	D	0.79108	0.992	T	0.68322	-0.5439	10	0.46703	T	0.11	-6.7923	16.6815	0.85292	0.0:0.0:1.0:0.0	.	1114	P55160	NCKPL_HUMAN	Q	1114;1064	ENSP00000293373:R1114Q;ENSP00000445596:R1064Q	ENSP00000293373:R1114Q	R	+	2	0	NCKAP1L	53222693	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	8.125000	0.89590	2.802000	0.96397	0.655000	0.94253	CGA	NCKAP1L-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000406195.1	182.289065	KEEP		+	182.50303	0.455285	56	67	---	---	---	---	0	1	1	379	0	170	72	92	0	170	2	1	1	588	920	2	1611	72	92	0	170	7	TP
ERBB3	2065	broad.mit.edu	37	12	56487212	56487212	+	Missense_Mutation	SNP	G	G	A	rs144549266	by1000genomes	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr12:56487212G>A	ENST00000267101.3	+	12	1798	c.1358G>A	c.(1357-1359)cGt>cAt	p.R453H	ERBB3_ENST00000553131.1_5'Flank|ERBB3_ENST00000450146.2_Intron|ERBB3_ENST00000415288.2_Missense_Mutation_p.R394H	NM_001982.3	NP_001973.2	P21860	ERBB3_HUMAN	v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3	453		NA		NA	cranial nerve development|heart development|negative regulation of cell adhesion|negative regulation of neuron apoptosis|negative regulation of secretion|negative regulation of signal transduction|neuron apoptosis|phosphatidylinositol 3-kinase cascade|positive regulation of phosphatidylinositol 3-kinase cascade|regulation of cell proliferation|Schwann cell differentiation|transmembrane receptor protein tyrosine kinase signaling pathway|wound healing	basolateral plasma membrane|extracellular space|integral to plasma membrane|receptor complex	ATP binding|growth factor binding|protein heterodimerization activity|protein homodimerization activity|protein tyrosine kinase activator activity|receptor signaling protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity		NA	central_nervous_system(2)|lung(3)|ovary(1)|skin(1)|stomach(1)	8			OV - Ovarian serous cystadenocarcinoma(18;0.112)			AGTGCTGGGCGTATCTATATA	0.493	NA	NA		NA			NA				NA	NA	G	2	9e-04	NA	NA	2184	0.0035	1	,	,	NA	3e-04	NA	NA	NA	9e-04	0.9768	LOWCOV,EXOME	NA	NA	0.0014	SNP						NA		NA		NA		0							NA						99	101	100	NA	NA	NA	NA	12		NA								NA			NA				56487212		2203	4300	6503	SO:0001583	missense				HGNC:3431		Approved	uc001sjh.3	NA	A8K6L6|B4DIK7|B4DV32|E9PDT8|Q9BUD7	ENST00000267101.3	37	CCDS31833.1	2	9.157509157509158E-4	0	0.0	0	0.0	2	0.0034965034965034965	0	0.0	G	23.5	4.424022	0.83667	.	.	ENSG00000065361	ENST00000267101;ENST00000415288	T;T	0.43688	0.94;0.94	5.16	5.16	0.70880	EGF receptor, L domain (1);	0.109129	0.39407	N	0.001380	T	0.46444	0.1393	L	0.47190	1.495	0.80722	D	1	D;D	0.69078	0.991;0.997	P;P	0.56563	0.65;0.801	T	0.35176	-0.9799	10	0.40728	T	0.16	.	7.6566	0.28379	0.1712:0.0:0.8288:0.0	.	453;453	B4DGQ7;P21860	.;ERBB3_HUMAN	H	453;394	ENSP00000267101:R453H;ENSP00000408340:R394H	ENSP00000267101:R453H	R	+	2	0	ERBB3	54773479	0.238000	0.23825	1.000000	0.80357	0.996000	0.88848	2.351000	0.44071	2.676000	0.91093	0.655000	0.94253	CGT	ERBB3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000407619.3	9.980634	KEEP		+	23.214144	0.11236	10	79	---	---	---	---	0	0.122557	1	4	0	153	12	91	0	153	2	1	1	184	946	0	1110	12	91	0	153	2	TP
C12orf50	160419	broad.mit.edu	37	12	88379766	88379766	+	Silent	SNP	C	C	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr12:88379766C>T	ENST00000298699.2	-	11	1167	c.987G>A	c.(985-987)gcG>gcA	p.A329A	C12orf50_ENST00000550553.1_Silent_p.A290A	NM_152589.1	NP_689802.1	Q8NA57	CL050_HUMAN	chromosome 12 open reading frame 50	329		NA		NA					NA	NS(1)|breast(1)|endometrium(3)|kidney(2)|large_intestine(4)|lung(17)|ovary(1)|skin(3)|urinary_tract(2)	34						ATGCATTCTCCGCATTTCGAT	0.468	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						196	188	190	NA	NA	NA	NA	12		NA								NA			NA				88379766		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:26665	NM_152589	Approved	uc001tam.1	NA	Q6P674	ENST00000298699.2	37	CCDS9031.1																																																																																			C12orf50-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000406328.1	22.773111	KEEP		-	44.64652	0.114094	17	132	---	---	---	---	0	0	0	0	0	170	21	156	0	170	2	1	1	65	327	0	403	21	156	0	170	2	TP
DNAH3	55567	broad.mit.edu	37	16	21063182	21063182	+	Silent	SNP	G	G	A			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr16:21063182G>A	ENST00000261383.3	-	29	4046	c.4047C>T	c.(4045-4047)gaC>gaT	p.D1349D	DNAH3_ENST00000415178.1_Silent_p.D1349D	NM_017539.1	NP_060009.1	Q8TD57	DYH3_HUMAN	dynein, axonemal, heavy chain 3	1349	Stem (By similarity).	NA		NA	ciliary or flagellar motility|microtubule-based movement	axonemal dynein complex|cilium axoneme|cytoplasm|microtubule	ATP binding|microtubule motor activity		NA	NS(3)|autonomic_ganglia(1)|breast(12)|central_nervous_system(3)|cervix(2)|endometrium(15)|haematopoietic_and_lymphoid_tissue(4)|kidney(10)|large_intestine(42)|liver(2)|lung(57)|ovary(14)|pancreas(1)|prostate(7)|skin(11)|stomach(5)|upper_aerodigestive_tract(7)|urinary_tract(6)	202				GBM - Glioblastoma multiforme(48;0.207)		TGGCCACCACGTCGCGGGCTG	0.517	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						100	96	98	NA	NA	NA	NA	16		NA								NA			NA				21063182		2201	4300	6501	SO:0001819	synonymous_variant			ENSG00000158486	HGNC:2949	NM_017539	Approved	uc010vbe.2	NA	O00437|O15437|O43326|Q3C0H2|Q8WUP9|Q9UEM3|Q9UEM5|Q9UG35	ENST00000261383.3	37	CCDS10594.1																																																																																			DNAH3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000207361.1	187.68747	KEEP		-	188.801312	0.409091	63	91	---	---	---	---	0	0	0	0	0	195	76	117	0	195	2	1	1	310	676	0	988	76	117	0	195	2	TP
DNAH3	55567	broad.mit.edu	37	16	21133323	21133323	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr16:21133323C>A	ENST00000261383.3	-	10	1526	c.1527G>T	c.(1525-1527)tgG>tgT	p.W509C	CTC-508F8.1_ENST00000575612.1_RNA|DNAH3_ENST00000415178.1_Missense_Mutation_p.W509C	NM_017539.1	NP_060009.1	Q8TD57	DYH3_HUMAN	dynein, axonemal, heavy chain 3	509	Stem (By similarity).	NA		NA	ciliary or flagellar motility|microtubule-based movement	axonemal dynein complex|cilium axoneme|cytoplasm|microtubule	ATP binding|microtubule motor activity		NA	NS(3)|autonomic_ganglia(1)|breast(12)|central_nervous_system(3)|cervix(2)|endometrium(15)|haematopoietic_and_lymphoid_tissue(4)|kidney(10)|large_intestine(42)|liver(2)|lung(57)|ovary(14)|pancreas(1)|prostate(7)|skin(11)|stomach(5)|upper_aerodigestive_tract(7)|urinary_tract(6)	202				GBM - Glioblastoma multiforme(48;0.207)		GTATTAATTCCCAGCAGCCAT	0.363	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						102	100	101	NA	NA	NA	NA	16		NA								NA			NA				21133323		2201	4300	6501	SO:0001583	missense			ENSG00000158486	HGNC:2949	NM_017539	Approved	uc010vbe.2	NA	O00437|O15437|O43326|Q3C0H2|Q8WUP9|Q9UEM3|Q9UEM5|Q9UG35	ENST00000261383.3	37	CCDS10594.1	.	.	.	.	.	.	.	.	.	.	C	15.25	2.778727	0.49891	.	.	ENSG00000158486	ENST00000261383;ENST00000415178;ENST00000396036	T;T	0.22134	1.97;2.13	5.36	5.36	0.76844	.	0.000000	0.85682	D	0.000000	T	0.42810	0.1219	L	0.55990	1.75	0.80722	D	1	D;D	0.89917	0.996;1.0	P;D	0.79108	0.63;0.992	T	0.08166	-1.0735	10	0.38643	T	0.18	.	17.867	0.88797	0.0:1.0:0.0:0.0	.	509;480	Q8TD57;Q8TD57-2	DYH3_HUMAN;.	C	509;509;480	ENSP00000261383:W509C;ENSP00000394245:W509C	ENSP00000261383:W509C	W	-	3	0	DNAH3	21040824	1.000000	0.71417	0.995000	0.50966	0.585000	0.36419	5.696000	0.68287	2.511000	0.84671	0.655000	0.94253	TGG	DNAH3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000207361.1	55.430177	KEEP		-	61.102789	0.235955	21	68	---	---	---	---	0	0.05749386	0	2	0	77	25	83	0	77	2	1	1	208	628	0	807	25	83	0	77	2	TP
TP53	7157	broad.mit.edu	37	17	7578475	7578475	+	Missense_Mutation	SNP	G	G	A	rs137852790|rs137852791		GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr17:7578475G>A	ENST00000420246.2	-	5	587	c.455C>T	c.(454-456)cCg>cTg	p.P152L	TP53_ENST00000574684.1_5'Flank|TP53_ENST00000413465.2_Missense_Mutation_p.P152L|TP53_ENST00000455263.2_Missense_Mutation_p.P152L|TP53_ENST00000269305.4_Missense_Mutation_p.P152L|TP53_ENST00000359597.4_Missense_Mutation_p.P152L|TP53_ENST00000445888.2_Missense_Mutation_p.P152L	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	152	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	P -> A (in sporadic cancers; somatic mutation).|P -> L (in LFS; germline mutation and in sporadic cancers; somatic mutation).|P -> Q (in sporadic cancers; somatic mutation).|P -> R (in sporadic cancers; somatic mutation).|P -> S (in sporadic cancers; somatic mutation).|P -> T (in sporadic cancers; somatic mutation).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.P152L(66)|p.P152R(8)|p.0?(8)|p.T150fs*16(6)|p.?(5)|p.P153fs*28(5)|p.P152fs*18(5)|p.P152fs*14(5)|p.P152Q(4)|p.P59L(2)|p.P20L(2)|p.P153fs*16(1)|p.P151_V173del23(1)|p.P152_P153del(1)|p.P59R(1)|p.P20R(1)|p.P152fs*28(1)|p.T57fs*16(1)|p.D148_T155delDSTPPPGT(1)|p.T150_P153delTPPP(1)|p.D148fs*23(1)|p.S149fs*72(1)|p.S149fs*17(1)|p.P152fs*27(1)|p.Q144_G154del11(1)|p.Q144fs*16(1)|p.T18fs*16(1)	NA	NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GGTGCCGGGCGGGGGTGTGGA	0.612	NA	111	"""Mis, N, F"""	NA	"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	132	Substitution - Missense(84)|Deletion - Frameshift(25)|Whole gene deletion(8)|Deletion - In frame(5)|Insertion - Frameshift(5)|Unknown(5)	large_intestine(22)|central_nervous_system(18)|upper_aerodigestive_tract(15)|oesophagus(10)|skin(9)|haematopoietic_and_lymphoid_tissue(8)|ovary(8)|prostate(8)|urinary_tract(7)|stomach(6)|bone(5)|breast(4)|lung(3)|liver(3)|vulva(2)|soft_tissue(2)|thyroid(1)|adrenal_gland(1)	GRCh37	CM941327	TP53	M	NA						51	52	52	NA	NA	NA	NA	17		NA								NA			NA				7578475		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	G	19.27	3.796249	0.70567	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315;ENST00000508793	D;D;D;D;D;D;D;D;D	0.99885	-7.5;-7.5;-7.5;-7.5;-7.5;-7.5;-7.5;-7.5;-7.5	5.59	5.59	0.84812	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99904	0.9954	M	0.91768	3.24	0.80722	D	1	P;P;D;D;D;P;D	0.89917	0.95;0.94;1.0;0.991;0.99;0.951;0.968	P;P;D;P;D;P;B	0.79108	0.53;0.774;0.992;0.561;0.91;0.812;0.377	D	0.96418	0.9309	10	0.87932	D	0	-5.4688	17.4784	0.87667	0.0:0.0:1.0:0.0	.	113;152;152;59;152;152;152	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	L	152;152;152;152;152;152;141;59;20;59;20;152	ENSP00000410739:P152L;ENSP00000352610:P152L;ENSP00000269305:P152L;ENSP00000398846:P152L;ENSP00000391127:P152L;ENSP00000391478:P152L;ENSP00000425104:P20L;ENSP00000423862:P59L;ENSP00000424104:P152L	ENSP00000269305:P152L	P	-	2	0	TP53	7519200	1.000000	0.71417	0.940000	0.37924	0.022000	0.10575	7.901000	0.87382	2.804000	0.96469	0.655000	0.94253	CCG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	149.205103	KEEP		-	149.270601	0.53012	44	39	---	---	---	---	1	1	95	20	1	111	49	45	1	111	6	1	1	1155	1129	2	1890	49	45	1	111	9	TP
UBB	7314	broad.mit.edu	37	17	16285560	16285560	+	Silent	SNP	T	T	C			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr17:16285560T>C	ENST00000302182.3	+	2	731	c.339T>C	c.(337-339)ccT>ccC	p.P113P	UBB_ENST00000395837.1_Silent_p.P113P|UBB_ENST00000535788.1_Intron|RP11-138I1.4_ENST00000583934.1_RNA|UBB_ENST00000578649.1_Intron|UBB_ENST00000395839.1_Silent_p.P113P	NM_018955.2	NP_061828.1	P0CG47	UBB_HUMAN	ubiquitin B	113	Ubiquitin-like 2.	NA		NA	activation of MAPK activity|anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|anti-apoptosis|apoptosis|cellular membrane organization|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA repair|endosome transport|epidermal growth factor receptor signaling pathway|G1/S transition of mitotic cell cycle|I-kappaB kinase/NF-kappaB cascade|induction of apoptosis by extracellular signals|innate immune response|JNK cascade|M/G1 transition of mitotic cell cycle|mRNA metabolic process|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|negative regulation of epidermal growth factor receptor signaling pathway|negative regulation of type I interferon production|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|nerve growth factor receptor signaling pathway|positive regulation of I-kappaB kinase/NF-kappaB cascade|positive regulation of NF-kappaB transcription factor activity|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|S phase of mitotic cell cycle|stress-activated MAPK cascade|T cell receptor signaling pathway|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|viral reproduction	cytosol|endocytic vesicle membrane|endosome membrane|nucleoplasm|plasma membrane	protein binding		NA	breast(1)|central_nervous_system(1)|endometrium(2)|large_intestine(2)|lung(3)|prostate(2)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	16				UCEC - Uterine corpus endometrioid carcinoma (92;0.0822)		AAGGCATCCCTCCCGACCAGC	0.557	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(163;1126 3406 34901)					NA		NA		NA		0							NA						115	112	113	NA	NA	NA	NA	17		NA								NA			NA				16285560		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000170315	HGNC:12463	NM_018955	Approved	uc002gpx.3	NA	P02248|P02249|P02250|P62988|Q29120|Q6LBL4|Q6LDU5|Q8WYN8|Q91887|Q91888|Q9BWD6|Q9BX98|Q9UEF2|Q9UEG1|Q9UEK8|Q9UPK7	ENST00000302182.3	37	CCDS11177.1																																																																																			UBB-001	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000130458.2	-14.607051	KEEP		+	11.900579	0.042373	5	113	---	---	---	---	1	0.8858422	2462	5514	2	113	6	131	2	113	235	0	0	0	0	0	0	6	131	2	113	2	TP
CPD	1362	broad.mit.edu	37	17	28783319	28783319	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr17:28783319A>G	ENST00000225719.4	+	16	3459	c.3383A>G	c.(3382-3384)aAt>aGt	p.N1128S	CPD_ENST00000584051.1_3'UTR|CPD_ENST00000543464.2_Missense_Mutation_p.N881S	NM_001304.4	NP_001295.2	O75976	CBPD_HUMAN	carboxypeptidase D	1128	Carboxypeptidase-like 3.	NA		NA	proteolysis	integral to membrane	metallocarboxypeptidase activity|serine-type carboxypeptidase activity|zinc ion binding		NA	central_nervous_system(1)|endometrium(4)|kidney(1)|large_intestine(9)|liver(1)|lung(13)|skin(5)|stomach(1)|urinary_tract(1)	36						CTTTATGCAAATAATCATCCA	0.363	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						76	69	71	NA	NA	NA	NA	17		NA								NA			NA				28783319		2203	4300	6503	SO:0001583	missense			ENSG00000108582	HGNC:2301	NM_001304	Approved	uc002hfb.2	NA	O15377|Q86SH9|Q86XE6	ENST00000225719.4	37	CCDS11257.1	.	.	.	.	.	.	.	.	.	.	A	13.15	2.152029	0.38021	.	.	ENSG00000108582	ENST00000225719;ENST00000543464	T;T	0.03152	4.03;4.03	5.05	3.97	0.46021	Peptidase M14, carboxypeptidase A (2);	0.180038	0.45867	N	0.000325	T	0.02193	0.0068	N	0.13198	0.31	0.43896	D	0.99652	B;B	0.14805	0.0;0.011	B;B	0.19666	0.001;0.026	T	0.36040	-0.9764	10	0.02654	T	1	.	9.9411	0.41580	0.92:0.0:0.08:0.0	.	881;1128	F5GZH6;O75976	.;CBPD_HUMAN	S	1128;881	ENSP00000225719:N1128S;ENSP00000444443:N881S	ENSP00000225719:N1128S	N	+	2	0	CPD	25807445	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	3.348000	0.52209	0.782000	0.33613	0.533000	0.62120	AAT	CPD-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256214.3	94.145863	KEEP		+	94.280713	0.448276	26	32	---	---	---	---	1	1	42	12	0	106	33	37	0	106	2	0	0	0	0	0	0	33	37	0	106	2	TP
POLRMT	5442	broad.mit.edu	37	19	625254	625254	+	Splice_Site	SNP	C	C	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr19:625254C>T	ENST00000588649.2	-	4	907	c.822_splice	c.e4-1	p.G275_splice	LLNLR-299G3.1_ENST00000607288.1_RNA	NM_005035.3	NP_005026.3	O00411	RPOM_HUMAN	polymerase (RNA) mitochondrial (DNA directed)	275		NA		NA	transcription initiation from mitochondrial promoter	mitochondrial nucleoid	DNA binding|DNA-directed RNA polymerase activity|protein binding		NA	cervix(2)|endometrium(3)|large_intestine(1)|lung(9)|ovary(1)|pancreas(2)|prostate(1)|stomach(1)	20		all_epithelial(18;2.78e-22)|Acute lymphoblastic leukemia(61;2.53e-14)|all_hematologic(61;8.18e-10)|Lung NSC(49;3.55e-06)|all_lung(49;5.41e-06)|Breast(49;4.08e-05)|Hepatocellular(1079;0.137)|Renal(1328;0.228)		UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|OV - Ovarian serous cystadenocarcinoma(105;1.09e-113)|Epithelial(107;3.79e-112)|all cancers(105;1.67e-104)|BRCA - Breast invasive adenocarcinoma(158;0.00136)|STAD - Stomach adenocarcinoma(1328;0.18)		TTGAAGGCACCCTGGGAGACC	0.612	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						73	76	75	NA	NA	NA	NA	19		NA								NA			NA				625254		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000099821	HGNC:9200	NM_005035	Approved	uc002lpf.1	NA	O60370	ENST00000588649.2	37	CCDS12036.1	.	.	.	.	.	.	.	.	.	.	.	16.99	3.272882	0.59649	.	.	ENSG00000099821	ENST00000215591	T	0.58060	0.36	4.37	4.37	0.52481	.	0.000000	0.85682	D	0.000000	T	0.75496	0.3857	M	0.86953	2.85	0.80722	D	1	D	0.76494	0.999	D	0.74023	0.982	T	0.81747	-0.0791	10	0.87932	D	0	-36.3204	15.9313	0.79663	0.0:1.0:0.0:0.0	.	275	O00411	RPOM_HUMAN	S	275	ENSP00000215591:G275S	ENSP00000215591:G275S	G	-	1	0	POLRMT	576254	1.000000	0.71417	0.982000	0.44146	0.033000	0.12548	3.411000	0.52672	1.985000	0.57927	0.555000	0.69702	GGT	POLRMT-001	KNOWN	upstream_ATG|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000452172.3	28.192561	KEEP	Missense_Mutation	-	45.899137	0.128788	17	115	---	---	---	---	0	0.3389925	0	9	0	149	23	156	0	149	2	1	1	529	1332	3	1884	23	156	0	149	9	TP
MATK	4145	broad.mit.edu	37	19	3778348	3778348	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr19:3778348C>T	ENST00000310132.6	-	14	1755	c.1357G>A	c.(1357-1359)Gtg>Atg	p.V453M	MATK_ENST00000395045.2_Missense_Mutation_p.V454M|MATK_ENST00000395040.2_Missense_Mutation_p.V412M|MATK_ENST00000585778.1_Missense_Mutation_p.V452M	NM_139355.2	NP_647612.1	P42679	MATK_HUMAN	megakaryocyte-associated tyrosine kinase	453	Protein kinase.	NA		NA	cell proliferation|mesoderm development|positive regulation of cell proliferation	cytoplasm|nucleus	ATP binding|non-membrane spanning protein tyrosine kinase activity	p.V454L(1)|p.V453L(1)	NA	central_nervous_system(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(4)|lung(13)|ovary(1)|skin(2)|stomach(2)|urinary_tract(1)	26		Hepatocellular(1079;0.137)		UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|BRCA - Breast invasive adenocarcinoma(158;0.00461)|STAD - Stomach adenocarcinoma(1328;0.18)		AGGACGTGCACGGGGCCTGGA	0.697	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		2	Substitution - Missense(2)	lung(2)					NA						27	33	31	NA	NA	NA	NA	19		NA								NA			NA				3778348		2203	4293	6496	SO:0001583	missense				HGNC:6906	NM_139355	Approved	uc002lyt.3	NA		ENST00000310132.6	37	CCDS12114.1	.	.	.	.	.	.	.	.	.	.	C	13.97	2.395298	0.42512	.	.	ENSG00000007264	ENST00000395045;ENST00000310132;ENST00000395040	D;D;D	0.84146	-1.81;-1.81;-1.81	3.68	-0.0265	0.13930	Serine-threonine/tyrosine-protein kinase (2);Protein kinase-like domain (1);Tyrosine-protein kinase, catalytic domain (1);Protein kinase, catalytic domain (1);	0.308822	0.25601	N	0.029558	D	0.82559	0.5063	L	0.39566	1.225	0.09310	N	1	D;D;D	0.62365	0.969;0.991;0.969	P;P;P	0.54965	0.66;0.765;0.66	T	0.74426	-0.3669	10	0.87932	D	0	-23.333	6.8013	0.23752	0.0:0.523:0.0:0.477	.	453;454;453	F1T0G6;B3KNZ9;P42679	.;.;MATK_HUMAN	M	454;453;412	ENSP00000378485:V454M;ENSP00000308734:V453M;ENSP00000378481:V412M	ENSP00000308734:V453M	V	-	1	0	MATK	3729348	0.000000	0.05858	0.000000	0.03702	0.539000	0.34962	-0.144000	0.10280	-0.118000	0.11851	0.561000	0.74099	GTG	MATK-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000453639.1	17.008377	KEEP		-	25.143738	0.147059	10	58	---	---	---	---	0	0.3999267	0	10	0	68	11	75	0	68	2	1	1	247	1601	0	1688	11	75	0	68	2	TP
AHCY	191	broad.mit.edu	37	20	32873385	32873385	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr20:32873385C>T	ENST00000538132.1	-	9	1330	c.944G>A	c.(943-945)cGg>cAg	p.R315Q	AHCY_ENST00000217426.2_Missense_Mutation_p.R343Q	NM_001161766.1	NP_001155238.1	P23526	SAHH_HUMAN	adenosylhomocysteinase	343		NA		NA	methylation|xenobiotic metabolic process	cytosol|melanosome	adenosylhomocysteinase activity|protein binding		NA	endometrium(6)|large_intestine(4)|lung(7)|skin(1)|upper_aerodigestive_tract(1)	19						GTTGACCAGCCGACCCTCGGC	0.627	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						75	64	67	NA	NA	NA	NA	20		NA								NA			NA				32873385		2203	4300	6503	SO:0001583	missense			ENSG00000101444	HGNC:343	NM_000687	Approved	uc002xai.3	NA	A8K307|E1P5P2|Q96A36	ENST00000538132.1	37	CCDS54457.1	.	.	.	.	.	.	.	.	.	.	C	18.45	3.625643	0.66901	.	.	ENSG00000101444	ENST00000217426;ENST00000538132	T;T	0.80304	-1.36;-1.35	5.1	4.16	0.48862	S-adenosyl-L-homocysteine hydrolase, NAD binding (1);	0.108822	0.64402	N	0.000008	D	0.86385	0.5920	H	0.96861	3.895	0.80722	D	1	B	0.27117	0.168	B	0.21360	0.034	D	0.87069	0.2158	10	0.87932	D	0	.	13.9526	0.64129	0.0:0.9265:0.0:0.0735	.	343	P23526	SAHH_HUMAN	Q	343;315	ENSP00000217426:R343Q;ENSP00000442820:R315Q	ENSP00000217426:R343Q	R	-	2	0	AHCY	32337046	1.000000	0.71417	0.997000	0.53966	0.771000	0.43674	6.057000	0.71119	1.316000	0.45131	0.650000	0.86243	CGG	AHCY-006	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000470304.1	145.535208	KEEP		-	146.112706	0.422018	46	63	---	---	---	---	1	1	246	219	0	131	59	82	0	131	2	0	0	0	0	0	0	59	82	0	131	2	TP
ADAMTS1	9510	broad.mit.edu	37	21	28210446	28210446	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-4065-Tumor-SM-325IF	GBM-TCGA-19-4065-Normal-SM-325IH	g.chr21:28210446A>G	ENST00000284984.2	-	9	2810	c.2356T>C	c.(2356-2358)Tcc>Ccc	p.S786P		NM_006988.3	NP_008919.3	Q9UHI8	ATS1_HUMAN	ADAM metallopeptidase with thrombospondin type 1 motif, 1	786	Spacer.	NA		NA	integrin-mediated signaling pathway|negative regulation of cell proliferation|proteolysis		heparin binding|zinc ion binding		NA	central_nervous_system(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(12)|lung(20)|ovary(2)|prostate(2)|skin(1)|urinary_tract(1)	42		Breast(209;0.000962)		Lung(58;0.215)		TCTAAGGTGGACAAAGTGTAG	0.468	NA	NA		NA			NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						80	66	71	NA	NA	NA	NA	21		NA								NA			NA				28210446		2203	4300	6503	SO:0001583	missense			ENSG00000154734	HGNC:217		Approved	uc002ymf.3	NA	D3DSD5|Q9NSJ8|Q9P2K0|Q9UH83|Q9UP80	ENST00000284984.2	37	CCDS33524.1	.	.	.	.	.	.	.	.	.	.	A	21.7	4.193765	0.78902	.	.	ENSG00000154734	ENST00000284984	T	0.55234	0.53	5.55	5.55	0.83447	ADAM-TS Spacer 1 (1);	.	.	.	.	T	0.72195	0.3430	M	0.76002	2.32	0.58432	D	0.999997	D	0.69078	0.997	D	0.72982	0.979	T	0.75371	-0.3341	9	0.66056	D	0.02	.	15.8689	0.79091	1.0:0.0:0.0:0.0	.	786	Q9UHI8	ATS1_HUMAN	P	786	ENSP00000284984:S786P	ENSP00000284984:S786P	S	-	1	0	ADAMTS1	27132317	1.000000	0.71417	0.999000	0.59377	0.959000	0.62525	5.237000	0.65360	2.333000	0.79357	0.482000	0.46254	TCC	ADAMTS1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000171650.1	24.451028	KEEP		-	27.814321	0.209302	9	34	---	---	---	---	1	0.9965481	12	30	0	47	11	41	0	47	2	0	0	0	0	0	0	11	41	0	47	2	TP
